ImmunoPrecise Antibodies
IPA
#9886
Rank
NZ$34.69 M
Marketcap
$0.76
Share price
-2.49%
Change (1 day)
-63.11%
Change (1 year)

Earnings for ImmunoPrecise Antibodies (IPA)

Earnings in 2025 (TTM): -NZ$62.27 Million

According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are NZ$17.17 Million. In 2024 the company made an earning of -NZ$60.57 Million a decrease over its 2023 earnings that were of -NZ$19.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoPrecise Antibodies from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$62.27 Million2.8%
2024 -NZ$60.57 Million211.9%
2023 -NZ$19.42 Million-41.74%
2022 -NZ$33.34 Million63.41%
2021 -NZ$20.4 Million519.54%
2020 -NZ$3.3 Million-58.53%
2019 -NZ$7.94 Million37.19%
2018 -NZ$5.79 Million6.4%
2017 -NZ$5.44 Million-2968.28%
2016 NZ$0.18 M-614.98%
2015 -NZ$0.04 Million-60.32%
2014 -NZ$0.1 Million-186.81%
2013 NZ$0.1 M-166.36%
2012 -NZ$0.17 Million-59.28%
2011 -NZ$0.4 Million
2004 -NZ$0.23 Million-41.04%
2003 -NZ$0.39 Million129.66%
2002 -NZ$0.17 Million-32.91%
2001 -NZ$0.26 Million50.61%
2000 -NZ$0.17 Million-16.18%
1999 -NZ$0.21 Million-1.56%
1998 -NZ$0.21 Million-39.38%
1997 -NZ$0.34 Million